Molecular cytogenetic characterization of Sézary syndrome.
about
Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and managementExpression of human endogenous retrovirus-w including syncytin-1 in cutaneous T-cell lymphomaLoss of nuclear pro-IL-16 facilitates cell cycle progression in human cutaneous T cell lymphoma.Integrated genomic analysis of sézary syndromeTP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythrodermaWHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects.Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.EPHA4 is overexpressed but not functionally active in Sézary syndrome.Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genesCharacterization of the DNA copy-number genome in the blood of cutaneous T-cell lymphoma patients.Genetic alterations in Sezary syndrome.Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management.Mature T-cell leukemias: Molecular and Clinical Aspects.Molecular genetic and cytogenetic analysis of a primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma.BCL2 and JUNB abnormalities in primary cutaneous lymphomas.Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndromeTruSeq-Based Gene Expression Analysis of Formalin-Fixed Paraffin-Embedded (FFPE) Cutaneous T-Cell Lymphoma Samples: Subgroup Analysis Results and Elucidation of Biases from FFPE Sample Processing on the TruSeq Platform.Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome vs. HTLV-1+ leukemic cell lines.Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management.Diagnosing erythrodermic cutaneous T-cell lymphoma.CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma.
P2860
Q27024076-CF12C8E1-5729-4D0B-B0CA-06289F0CC0D1Q35009341-5754B2E2-81B1-4F7A-BD45-A3EA5F7B82CBQ35578556-202CD997-5140-4B3F-B1DB-6E42A695D73BQ35910314-4D7103B1-F568-458E-90B0-EB9DB4877AEFQ36310531-11BBFBB8-4C10-4BC0-A53C-BD50C6A3068CQ36315227-0108FD80-E6A9-4B1C-8DBE-C8F68A2D330EQ36470196-A8328CD8-9B52-448F-9F62-D5F7AA7E3C75Q36544714-2536DC17-7784-4859-B490-E530B0026B43Q36793430-636BC10A-8776-48C6-BDB4-980645CA0D18Q37346462-F94AEF34-12E4-46C8-9C26-B668650FCCFBQ37842481-184C97C8-293C-41C6-8CBA-74A5906CBC56Q37944565-921AE8C7-666D-4063-9B4A-6099ADA874A4Q38598546-54243832-0750-4949-BA32-CDF7EADB5161Q40202514-ED0972CE-5EC9-45D8-8D65-9B913E1C1342Q40514110-068E19CF-094A-4141-8F20-77360AAA4AC6Q41077253-28A81A33-9A81-4618-883C-E5A2DEBC6B3AQ42270898-3D713A29-6B3D-4DB4-B359-67899B6162DBQ47100819-C85A5A55-155D-4D58-8698-6939D347B689Q48034709-FCA5D891-A190-4DB7-AEBE-FC0FC3F45775Q51968694-E88CDDE2-6659-46BA-B5DF-998A0ED93750Q54695363-5D34CEE0-EFC5-4499-B911-A3EAA9CA9DD7
P2860
Molecular cytogenetic characterization of Sézary syndrome.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Molecular cytogenetic characterization of Sézary syndrome.
@ast
Molecular cytogenetic characterization of Sézary syndrome.
@en
type
label
Molecular cytogenetic characterization of Sézary syndrome.
@ast
Molecular cytogenetic characterization of Sézary syndrome.
@en
prefLabel
Molecular cytogenetic characterization of Sézary syndrome.
@ast
Molecular cytogenetic characterization of Sézary syndrome.
@en
P2093
P2860
P356
P1476
Molecular cytogenetic characterization of Sézary syndrome.
@en
P2093
Barbara Czepulkowski
Bryan D Young
Debra M Lillington
Robin Russell-Jones
Sean Whittaker
P2860
P304
P356
10.1002/GCC.10152
P577
2003-03-01T00:00:00Z